Printer Friendly

KRELITZ INDUSTRIES ANNOUNCES THIRD QUARTER RESULTS

 KRELITZ INDUSTRIES ANNOUNCES THIRD QUARTER RESULTS
 MINNEAPOLIS, March 17 /PRNewswire/ -- Krelitz Industries, Inc.


(NASDAQ: KRLZ) announced today that net sales from continuing operations for the nine months were $186,918,000, as compared to $195,598,000 last year. Loss from continuing operations was $1,010,000, or $.29 per share, compared to income of $618,000, or $.18 per share, for the same period last year.
 Sales from continuing operations for the third quarter ended Jan. 31, 1992, were $63,369,000, compared with the $67,991,000 reported for the same period last year. Loss from continuing operations was $111,000, or $.03 per share, compared to income of $116,000, or $.03 per share, for the third quarter of last year.
 Sales increases from existing and new customers in the drug distribution business of approximately $23,900,000 did not fully mitigate the previously reported loss of a significant customer. The loss from continuing operations in the first nine months of fiscal 1992 was primarily attributed to lower gross profit margins and increased operating expenses as compared to last year. During the third quarter of fiscal 1992 the company recorded a $499,000 pre-tax gain on the sale of real estate.
 Krelitz Industries, Inc. is the largest independent drug wholesaler in the Upper Midwest. The company also distributes general merchandise and develops and markets computerized management systems. The company's common stock is traded nationally over-the-counter under the NASDAQ symbol: KRLZ.
 KRELITZ INDUSTRIES, INC.
 SELECTED CONSOLIDATED FINANCIAL DATA
 (In thousands, except per-share amounts)
 Three Months Ended Nine Months Ended
 1/31/92 1/31/91 1/31/92 1/31/91
 Net sales $63,369 $67,991 $186,918 $195,598
 Operating income (loss) $(202) $776 $(680) $2,402
 Income (loss) from
 continuing operations,
 net of taxes $(111) $116 $(1,010) $618
 Gain from discontinued
 operations, net of taxes -- -- -- $17
 Net income (loss) $(111) $116 $(1,010) $635
 Income (loss) per share
 of common stock:
 Continuing operations $(.03) $.03 $(.29) $.18
 Discontinued operations -- -- -- --
 Net income (loss) $(.03) $.03 $(.29) $.18
 Weighted average number of
 shares outstanding
 (restated for stock split) 3,474 3,474 3,474 3,474
 -0- 3/17/92 R
 /CONTACT: Barry M. Krelitz, 612-936-0401, or Dennis J. Allingham, 612-347-9729, both of Krelitz Industries/
 (KRLZ) CO: Krelitz Industries, Inc. ST: Minnesota IN: MTC SU: ERN


KH -- MN011R -- 8970 03/17/92 17:54 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 17, 1992
Words:399
Previous Article:NU-KOTE INTERNATIONAL ACQUIRES INTERNATIONAL COMMUNICATION MATERIALS
Next Article:SHERMAN RETURNS TO PARAMOUNT COMMUNICATIONS AS SENIOR VP-CORPORATE COMMUNICATIONS
Topics:


Related Articles
KRELITZ INDUSTRIES ANNOUNCES SECOND QUARTER RESULTS
KRELITZ INDUSTRIES ANNOUNCES THIRD QUARTER RESULTS
KRELITZ INDUSTRIES ANNOUNCES RESIGNATION OF ALLINGHAM AS SENIOR VICE PRESIDENT, CHIEF FINANCIAL OFFICER AND DIRECTOR
KRELITZ INDUSTRIES ANNOUNCES MANAGEMENT CHANGES
KRELITZ INDUSTRIES, INC. REPORTS SALES AND EARNINGS AND DEFINITIVE BANK AGREEMENT
KRELITZ INDUSTRIES INC. FINALIZES ONE MILLION DOLLAR INVESTMENT FROM INSTITUTIONAL INVESTOR
KRELITZ INDUSTRIES, INC., DEFINITIVE ACQUISITION AGREEMENT SIGNED
KRELITZ INKS SUPPLIER PACT WITH PAMIDA
TARO PHARMACEUTICAL INDUSTRIES ANNOUNCES INCREASED SALES AND EARNINGS IN THIRD QUARTER
D & K WHOLESALE DRUG, INC. TO ACQUIRE KRELITZ INDUSTRIES, INC.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters